ClinicalTrials.Veeva

Menu

Multimodal Imaging Analysis of Spinal Tumors

P

Peking University

Status

Completed

Conditions

Bone Tumor

Treatments

Diagnostic Test: radiomics

Study type

Observational

Funder types

Other

Identifiers

NCT04955522
M2019501

Details and patient eligibility

About

In this study, we retrospectively analyzed the imaging data of spinal tumors to find out more imaging features of spinal tumors, in order to provide more accurate reference for the diagnosis of spinal tumors.

Full description

Bone tumors account for 1-2% of total body tumors, and spinal tumors only account for 6.5% of total body tumors. Because of the low incidence rate, the number of patients and the attention in this field are far lower than other tumors, so far, all the researches on spinal tumors are relatively lacking. Because the diagnosis of bone tumor needs the combination of clinical, imaging and pathological to make a more accurate diagnosis, so the imaging diagnosis of spinal tumor is very important. In this study, through retrospective analysis of a variety of imaging data of patients with spinal tumor, measurement and recording of spinal tumor image related parameters, and statistical analysis, in order to find out more imaging characteristics of patients with spinal tumor, more accurate diagnosis of lesions, and provide more help for clinical decision-making.

Enrollment

242 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Complete and accurate clinical and pathological data are available;Imaging examination was performed in our hospital

Exclusion criteria

  • Patients with missing image data and unclear image

Trial design

242 participants in 2 patient groups

metastases
Description:
patients with spinal metastases
Treatment:
Diagnostic Test: radiomics
multiple myeloma
Description:
patients with spinal multiple myeloma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems